17 E-Health and Integrated Care
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
BOOKTIVISM: the Power of Words
BOOKTIVISM: The Power of Words Book•ti•vi•sm(noun). 1. The mobilization of groups of concerned citizens produced by reading books offering powerful analyses of social or political issues. 2. A call to action based on the sharing of knowledge through books. 3. Books + activism = “booktivism.” 4. A term first used at the SellingSickness, 2013: People Before Profits conference in Washington, DC, see www.sellingsickness.com. Read. Discuss. Be thoughtful. Be committed. Here are some more suggestions to get you started: 1) Set up a reading group on disease-mongering among interested friends and colleagues. If you do The books included in BOOKTIVISM celebrate recent contributions to the broad topic of disease- not already have a group of interested readers, post a notice in your workplace, library, community mongering, especially as they examine the growing prevalence and consequences of overtreatment, center, apartment building, etc. Once you have a group, decide where to meet. Book clubs can overscreening, overmarketing, and overdiagnosis (see Lynn Payer’s 1992 classic, Disease-Mongers: How meet anywhere – at homes, in dorms, in pubs, in coffeehouses, at libraries, even online! Decide on Doctors, Drug Companies, and Insurers Are Making You Feel Sick, for an introduction to timing and format. Will you meet monthly/bimonthly? You’ll need time to prepare for the sessions, disease-mongering). but not so much time that you lose touch. Circulate the reading guide. It is usually best if one person leads each discussion, to have some questions at the ready and get things rolling. Although the challenge to disease-mongering is not unprecedented (the women’s health movement of the 1970s was another key historical moment), these books represent an impressive groundswell OR, maybe you’d like to of amazing, powerful, brilliant, and often deeply unsettling investigations by physicians, health scientists, 2) Set up a lecture/discussion group. -
Comment from Universal Health Coverage to Right Care for Health
Comment THELANCET-D-16-08652 REQUESTED [PII_REPLACE] Embargo: January 8, 2017—23:30 (GMT) From universal health coverage to right care for health Achieving universal health coverage is the most happen side-by-side in different countries, within Published Online important means to advance health and wellbeing during countries, among populations, within institutions, January 8, 2017 http://dx.doi.org/10.1016/PII the next decade. Too many countries—and not only in and even for a single person. This situation offers an low-income or middle-income settings—do not have a enormous (and currently poorly recognised) opportunity See Online/Comment http://dx.doi.org/10.1016/ health system that provides “access to quality essential to tackle underuse and overuse together to achieve the S0140-6736(16)32570-3, and health-care services and access to safe, effective, quality right care for health and wellbeing. http://dx.doi.org/10.1016/ S0140-6736(16)32573-9 and affordable essential medicines and vaccines for all”, What is right care? In its simplest definition it is care See Online/Series 1 as described in Sustainable Development Goal 3.8. that weighs up benefits and harms, is patient-centred http://dx.doi.org/10.1016/PII, Even many high-income countries, such as the USA (taking individual circumstances, values, and wishes http://dx.doi.org/10.1016/ S0140-6736(16)32379-0, and the UK, see important inequalities in income, life into account), and is informed by evidence, including http://dx.doi.org/10.1016/ expectancy, and health outcomes,2,3 and the prevailing cost-effectiveness. -
Telemedicine Services for Remote Reporting and Dissemination Technology in Sub-Saharan Africa
Theme 2019: International Cooperation as Key Principle in Space Activities Telemedicine services for remote reporting and dissemination technology in Sub-Saharan Africa Silvana Dellepiane - Moira Gerace Telemedicine services for remote reporting and dissemination technology in Sub-Saharan Africa 4. A CASE STUDY: C.A.R. 1. INTRODUCTION • • Substainable Goals Geopolitical vision • WHO Leadership priorities and UHC • Healthcare and conditions of children • The logic ICT context • Hospital of Maïgaro • Culture, Cooperation and Technology • Telemedicine: Needs and requirements 5. DIGITAL DIVIDE and TELEMEDICINE IN AFRICA 2. E-Health • ICT technology Dissemination • Medicine-at-a-distance • Satellite communications • Telemedicine practice 6. TELEMEDICINE: A PILOT STUDY IN C.A.R. • WHO digital health • The approach • Maximising digital health technology AFRO • The Project development Region • The Project architecture • The software development 3. DATA PROTECTION • The platform • Medical records • The experiment on site • GDPR Legal issues 7. CONCLUSIONS Telemedicine services for remote reporting and dissemination technology in Sub-Saharan Africa 1. INTRODUCTION • Substainable Goals • WHO Leadership priorities and UHC • The logic ICT context • Culture, Cooperation and Technology End of 2015: transition from UNITED NATIONS Millennium Development Goals (MDGs) (proposed in the late 90s) to Sustainable Development Goals (SDGs). SDG 3 – Ensure healthy lives and promote well-being for all at all ages As one of the Sustainable Development Goals (SDGs) set by the UN at the September 2015 global summit held in New York, SDG 3 – better health care and general well-being has always been a major challenge, especially in the developing world. Workers in various industries that are supposed to propel economic growth can only maximise their productivity if they are physically well and fit to comfortably handle their jobs’ magnitudes. -
Health IT-Enabled Care Coordination and Redesign in Tennessee
FINAL CONTRACT REPORT Using Health IT in Practice Redesign: Impact of Health IT on Workflow Health IT-Enabled Care Coordination and Redesign in Tennessee Agency for Healthcare Research and Quality Advancing Excellence in Health Care www.ahrq.gov HEALTH IT Final Contract Report Health IT-Enabled Care Coordination and Redesign in Tennessee Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. HHSA 290-2010-00024I Prepared by: RTI International Research Triangle Park, NC Authors: Jonathan S. Wald, M.D., M.P.H., RTI International Laurie L. Novak, Ph.D., M.H.S.A., Vanderbilt University Medical Center (VUMC), Nashville, TN Christopher L. Simpson, M.A., VUMC Jason M. Slagle, Ph.D., VUMC Alison K. Banger, M.P.H., RTI International Neeraja B. Peterson, M.D., M.S., VUMC AHRQ Publication No. 15-0048-EF June 2015 This document is in the public domain and may be used and reprinted without permission except those copyrighted materials that are clearly noted in the document. Further reproduction of those copyrighted materials is prohibited without the specific permission of copyright holders. Suggested Citation: Wald JS, Novak LL, Simpson CL, et al. Health IT-Enabled Care Coordination and Redesign in Tennessee. (Prepared by RTI International, under Contract No. 290-2010-00024I). AHRQ Publication No. 15-0048-EF. Rockville, MD: Agency for Healthcare Research and Quality. June 2015. None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report. This project was funded by the Agency for Healthcare Research and Quality (AHRQ), U.S. -
Ehealth to Support Cancer Survivors Support to Ehealth Ehealth to Support Cancer Survivors
eHealth to support survivors cancer eHealth to support cancer survivors Development, implementation and evaluation of an interactive portal The end Wilma Kui jpers Wilma Kui jpers eHEALTH TO SUPPORT CANCER SURVIVORS DEVELOPMENT, IMPLEMENTATION AND EVALUATION OF AN INTERACTIVE PORTAL Wilma Kui jpers Address of correspondence Wilma Kuijpers Zamenhof 20 1961 GL Heemskerk, the Netherlands [email protected] +31 (0)6 22 15 77 82 © Copyright 2015: Wilma Kuijpers, the Netherlands All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or any information storage or retrieval system, without permission in writing from the author, or, when appropriate, from the publishers of the publications. ISBN: 978-90-365-4031-5 Department Health Technology and Services Research, University of Twente, HSS 16-011, ISSN 1878-4968 Cover design and layout: Rachel van Esschoten, DivingDuck Design (www.divingduckdesign.nl) Printing: Gildeprint Drukkerijen, Enschede The studies in this thesis were financially supported by a grant from Alpe d’Huzes (KWF 2010- 4584) The printing of this thesis was supported by The Netherlands Cancer Institute and ChipSoft. eHEALTH TO SUPPORT CANCER SURVIVORS DEVELOPMENT, IMPLEMENTATION AND EVALUATION OF AN INTERACTIVE PORTAL PROEFSCHRIFT ter verkrijging van de graad van doctor aan de Universiteit Twente, op gezag van de rector magnificus, prof. dr. H. Brinksma, volgens besluit van het College voor Promoties in het openbaar te verdedigen op vrijdag 4 maart 2016 om 12.45 uur door Wilma Kuijpers geboren op 7 december 1984 te Beverwijk Dit proefschrift is goedgekeurd door de promotoren: Prof. -
Gender Equity in Clinical Trials in Canada: Aspiration Or Achievement?
Osgoode Hall Law School of York University Osgoode Digital Commons Articles & Book Chapters Faculty Scholarship 2008 Gender Equity in Clinical Trials in Canada: Aspiration or Achievement? Roxanne Mykitiuk Osgoode Hall Law School of York University, [email protected] Patricia Peppin Source Publication: International Journal of Feminist Approaches to Bioethics 1:2 (2008) p. 100-124 Follow this and additional works at: https://digitalcommons.osgoode.yorku.ca/scholarly_works Part of the Law Commons Recommended Citation Mykitiuk, Roxanne and Patricia Peppin. "Gender Equity in Clinical Trials in Canada: Aspiration or Achievement?" International Journal of Feminist Approaches to Bioethics , vol. 1, no. 2, 2008, pp. 100-124. This Article is brought to you for free and open access by the Faculty Scholarship at Osgoode Digital Commons. It has been accepted for inclusion in Articles & Book Chapters by an authorized administrator of Osgoode Digital Commons. Gender Equity in Clinical Trials in Canada: Aspiration or Achievement? Patricia Peppin and Roxanne Mykitiuk (Fall 2008) 1:2 International Journal of Feminist Approaches to Bioethics 100- 124. Achieving gender equity in clinical trials requires that women be included in sufficient numbers to carry out analysis, that those sub-sample analyses be carried out, and that results be communicated in such a way as to expand medical knowledge, inform policy decisions and educate patients. In this article, we examine the extent to which Canada promotes gender equity through its laws and guidelines, viewed within the context of its drug safety system and its research ethics board structure. We analyze the structuring of information by the pharmaceutical industry and consider the impact of its promotional activities on the state of gender knowledge and health. -
Getting Results for Hematology Patients Through Access to the Electronic Health Record
doi:10.5737/1181912x163154158 Getting results for hematology patients through access to the electronic health record by David Wiljer, Sima Bogomilsky, Pamela Catton, Cindy perceive in accessing the records and their information-seeking Murray, Janice Stewart and Mark Minden behaviours, including internet usage, rather than clinical characteris - Abstract tics or educational levels (Fowles et al., 2004; Ross et al., 2005). The range of benefits of providing patients with access to their Purpose: To conduct a needs assessment to identify patient and records is still somewhat undefined (Ross & Lin, 2003). Although most provider perceptions about providing patients with access to their studies identify the need for further research in this area, there is some electronic health record in order to develop an online system that is evidence of an increase in patient satisfaction and improved patient appropriate for all stakeholders. Methods: Malignant hematology compliance with self-care (Ross, 2004; Winkelman & Leonard, 2004). patients were surveyed and health care providers were interviewed to Research also suggests that making electronic health records accessible identify issues and validate concerns reported in the literature. Based to patients may empower them (Ralston, Revere, Robins, & Goldberg, on the analysed data, a prototype will be designed to examine the fea - 2004; Ueckert et al., 2003). A recent study from Britain indicated that sibility and efficacy of providing patients with access to their elec - patients find it useful to have access to their health records, but they tronic health record and tailored information. Results: 61% of want to be included in the process of developing the system for patient patients reported using the internet to find health information; 89% access (Pyper et al., 2004). -
Preventing Overdiagnosis: How to Stop Harming the Healthy
MEDICALISATION bmj.com � BMJ blog: Elizabeth Loder on tackling unnecessary treatment in the US: This time “it feels diff erent” � Des Spence: The psychiatric oligarchs who medicalise normality (BMJ 2012;344:e3135) � Research: Overdiagnosis in publicly organised mammography screening programmes (BMJ 2009;339:b2587) Preventing overdiagnosis: how to stop harming the healthy Evidence is mounting that medicine is harming healthy people through ever earlier detection and ever wider definition of disease. With the announcement of an international conference to improve understanding of the problem of overdiagnosis, Ray Moynihan , Jenny Doust , and David Henry examine its causes and explore solutions edicine’s much hailed ability to help the sick is fast being challenged by its propensity to harm the healthy. A burgeon- ing scientifi c literature is fuel- M ling public concerns that too many people are being overdosed, 1 overtreated, 2 and overdiag- nosed. 3 Screening programmes are detecting early cancers that will never cause symptoms or death, 4 sensitive diagnostic technologies iden- tify “abnormalities” so tiny they will remain benign, 5 while widening disease defi nitions mean people at ever lower risks receive permanent medical labels and lifelong treatments that will fail to benefit many of them. 3 6 With estimates that more than $200bn (£128bn; €160bn) may be wasted on unnecessary treatment every year in the United States,7 the cumulative burden from overdiagnosis poses a signifi cant threat to human health. Narrowly defined , overdiagnosis occurs when people without symptoms are diagnosed with a disease that ultimately will not cause them to experience symptoms or early death.3 More broadly defi ned, overdiagnosis refers to the related problems of overmedicalisation and subsequent overtreatment, diagnosis creep, shift ing thresholds, and disease mongering, all processes helping to reclassify healthy people with mild problems or at low risk as sick. -
Amy S. Kelley Diane E. Meier Editors Challenges and Opportunities In
Aging Medicine Series Editors: Robert J. Pignolo · Mary A. Forciea · Jerry C. Johnson Amy S. Kelley Diane E. Meier Editors Meeting the Needs of Older Adults with Serious Illness Challenges and Opportunities in the Age of Health Care Reform Aging Medicine Robert J. Pignolo, MD, PhD; Mary A. Forciea, MD; Jerry C. Johnson, MD, Series Editors For further volumes: http://www.springer.com/series/7622 Amy S. Kelley • Diane E. Meier Editors Meeting the Needs of Older Adults with Serious Illness Challenges and Opportunities in the Age of Health Care Reform Editors Amy S. Kelley, M.D., M.S.H.S. Diane E. Meier, M.D. Brookdale Department of Geriatrics Brookdale Department of Geriatrics and Palliative Medicine and Palliative Medicine Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai New York , NY , USA New York , NY , USA ISBN 978-1-4939-0406-8 ISBN 978-1-4939-0407-5 (eBook) DOI 10.1007/978-1-4939-0407-5 Springer New York Heidelberg Dordrecht London Library of Congress Control Number: 2014945371 © Springer Science+Business Media New York 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. -
Provider Manual TABLE of CONTENTS INTRODUCTION Aspirus Arise Is Pleased to Welcome You As a Partner! Introduction
Provider Manual TABLE OF CONTENTS INTRODUCTION Aspirus Arise is pleased to welcome you as a partner! Introduction ...................................................................................................................................................3 The Aspirus Arise Provider Manual is designed and produced for Aspirus Arise Contact Aspirus Arise ................................................................................................................................4 providers to promote a clear understanding of our policies and procedures, About Aspirus Arise ....................................................................................................................................5 including provider services, outpatient prior authorization, claims, and eligibility. Product and Benefit Plans ........................................................................................................................6 The purpose of this manual is to answer some of the questions you may Member Primary Care Access Model .................................................................................................... 7 have regarding Aspirus Arise operations. As changes occur, this manual will be updated on a routine basis. Aspirus Arise reserves Appointment Scheduling Guidelines .....................................................................................................8 the right to revise or alter the material and information detailed in Medical Record Requirements ................................................................................................................9 -
Health, Market Forces, and Debate in Medical Care Room for Controversy
EDITORIAL Health, Market Forces, and Debate in Medical Care Room for Controversy Catarina Kiefe, MD, PhD, and Jeroan Allison, MD, MScEpi n this issue of Medical Care, we present a bundle of 3 manuscripts organized as “Point,” I“Counterpoint,” and “Reply.” We initially received the article, Vulnerability of Health to Market Forces, by Brezis and Wiist, as an unsolicited manuscript submitted for peer review; it did not clearly fit the mold of original data-driven research usually published in our journal. However, we believed the issue to be both so important and so controversial that it might justify starting a debate in the pages of Medical Care. Thus, we invited a Counterpoint and gave the authors of the initiating manuscript an opportunity to respond to the Counterpoint. Indeed, the debate does not end with these 3 articles. To continue the discussion, we have initiated a blog monitored by the Editors of Medical Care (http://journals.lww.com/lww-medicalcare/blog/PointCounterpoint/pages/ default.aspx). We hope to hear from our readers, and to continue the debate with a tone of scholarship and civility. Compared with the traditional editorial process, the Point-Counterpoint approach conveys significant advantages for the presentation of controversial topics. For example, editorials typically place the original work in context, but may not present opposing viewpoints. Letters to the editor generally focus on specific, and often idiosyncratic, concerns of the author; and rely on the chances of having read the original article. The Point-Counterpoint approach ensures a more global examination of the controversy and more carefully defines the relevant questions. -
Disease Mongering (Pseudo-Disease Promotion)
DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY Disease Mongering (Pseudo-Disease Promotion) NOTE Abstract Disease mongering is the promotion of pseudo-diseases by the pharmaceutical industry aiming at economic benefit. Medical equipment manufacturers, insurance companies, doctors or patient groups may also use it for monetary gain or influence. It has increased in parallel with society's 'medicalisation' and the growth of the pharmaceutical complex. Due to massive investments in marketing and lobbying, ample use of internet and media, and the emergence of new markets, it is becoming a matter of concern, and policy makers should be aware of its perils and consequences. IP/A/ENVI/NT/2012-20 November 2012 PE 492.462 EN This document was requested by the European Parliament's Committee on Environment, Public Health and Food Safety and produced internally in the Policy Department for Economic and Scientific Policy. AUTHORS Dr. Marcelo SOSA-IUDICISSA Dr. Purificación TEJEDOR DEL REAL RESPONSIBLE ADMINISTRATOR Dr. Marcelo SOSA-IUDICISSA Policy Department A: Economic and Scientific Policy European Parliament B-1047 Brussels E-mail: [email protected] LINGUISTIC VERSION Original: EN ABOUT THE EDITOR To contact the Policy Department or to subscribe to its newsletter please write to: [email protected] Manuscript completed in November 2012. Brussels, © European Union, 2012. This document is available on the Internet at: http://www.europarl.europa.eu/studies DISCLAIMER The opinions expressed in this document are the sole responsibility of the authors and do not necessarily represent the official position of the European Parliament.